Epitalon
← All compounds

Epitalon

Well Researched

Category 2Injection · Nasal spray · Oral

Epitalon (also called Epithalon or AEDG) is a synthetic four-amino-acid peptide based on a naturally occurring pineal gland peptide. Developed by Russian scientist Vladimir Khavinson and studied for over 35 years, Epitalon is primarily researched for its ability to activate telomerase, extend telomeres, and potentially slow cellular aging through multiple mechanisms including melatonin regulation and gene expression changes. Current Western dosing protocols typically use 50 to 100 times more than the original Russian research suggested. The evidence-based protocols listed here reflect doses closer to what the clinical literature actually supports.

How it works

Activates telomerase enzyme at extremely low concentrations (10⁻¹⁷ to 10⁻¹⁵ M) to maintain telomere length, stimulates pineal gland for melatonin production, modulates gene expression through epigenetic mechanisms, and enhances antioxidant enzyme systems.

Key benefits

  • Activates telomerase to help maintain telomere length
  • Enhances natural melatonin production for better sleep
  • Supports immune function and cellular repair
  • May slow key markers of cellular aging

Related goals

Injection

recommended

The most studied route for Epitalon with 30+ years of clinical use in Russia. Injection delivers the peptide systemically for telomerase activation, melatonin regulation, and anti-aging gene expression. Five protocols ranging from evidence-based microgram dosing to traditional Western milligram protocols.

Injection protocols

ProtocolDoseFrequency
Evidence-based (recommended)200-500mcgDaily
Conservative start100mcgDaily
Russian clinical equivalent300mcgDaily
Traditional Western (anecdotal)5-10mgDaily
Ultra-low dose50mcgDaily

Protocols are from published research literature. This is not medical advice. Dosing should be determined by a licensed clinician.

What to expect

Week 1-2

Enhanced morning energy, improved mood stability.

Week 2-4

Skin quality improvements, better wound healing.

Month 1-2

Measurable improvements in sleep quality via melatonin enhancement.

Month 3+

Cumulative telomerase activation and anti-aging benefits.

What to know

  • Generally well-tolerated with minimal side effects in studies
  • Corrected microgram dosing reduces risk of unnecessary peptide exposure
  • Theoretical concern about telomerase activation in cancer. Avoid if you have active cancer.
  • May cause mild injection site reactions
  • Some users report vivid dreams due to melatonin enhancement
  • No severe adverse events reported in 30+ years of Russian clinical use
  • Current Western protocols may represent significant overdosing

Also available as

Key research

Al-Dulaimi S et al. · Biogerontology · 2025
Khavinson VKh et al. · Bulletin of Experimental Biology and Medicine · 2003
Khavinson V et al. · Neuroendocrinology Letters · 2002
Khavinson VKh et al. · Advances in Gerontology · 2002